Medicines Development For Global Health

This study tests an experimental drug called dovramilast for people with moderate to severe leprosy type 2 reaction, a painful skin condition. About 45 adults will receive either 100 mg or 150 mg of dovramilast or standard treatments for 12 weeks. The goal is to see if the new dr…

This study tests if a new drug combination (moxidectin plus two other medicines) can safely treat three parasitic infections—lymphatic filariasis, scabies, and strongyloidiasis—in communities in Fiji. About 5,100 children and adults will receive either the new combination or a st…